Relic Pharma Limited
About Relic Pharma Limited
Data last updated:
Relic Pharma Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Relic Technologies Limited. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 04 May 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U67120MH1995PLC088000. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹3.25 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Hemant Kantilal Choksey and Baijoo Madhusudan Raval.
Its last annual general meeting (AGM) was held on 19 August 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at J – Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, India – 400002.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressJ – Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, India – 400002
- IndustryFinancial Services, Brokerage & Trading Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Relic Pharma Limited FY 2024 filings available
Financial Statement Summary of Relic Pharma Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Relic Pharma Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Relic Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Relic Pharma Limited
Relic Pharma Limited is audited by UDAY PASAD AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| UDAY PASAD AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Relic Pharma Limited
Relic Pharma has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hemant Kantilal Choksey | Director | 19 Apr 2014 | 12 Years 5 Months | Current |
| Baijoo Madhusudan Raval Also directs: Relic Technologies Limited, Arkaan Enterprises Private Limited | Director | 04 May 1995 | 31 Years 5 Months | Current |
| Uday Madhusudan Raval | Director | 04 May 1995 | 31 Years 5 Months | Current |
Ownership and Shareholding of Relic Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Relic Pharma Limited
Relic Pharma Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Relic Pharma Limited
Employment history and EPFO contributions of people linked to Relic Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Relic Pharma Limited
Relic Pharma has one previous CIN (Corporate Identification Number): U67120MH2004PTC088000. The current CIN is U67120MH1995PLC088000, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U67120MH1995PLC088000 | Current |
| U67120MH2004PTC088000 | Previous |
Recent Activity on Relic Pharma Limited
Relic Pharma Limited has 6 board changes on record since 1995: 3 appointments and 3 cessations. The latest: Hemant Kantilal Choksey ceased to be Additional Director on 30 Sep 2014.
Credit Ratings, Litigation & Regulatory Alerts for Relic Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Relic Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Relic Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Relic Pharma Limited
Relic Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Relic Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Relic Pharma Limited
Relic Pharma is an active public limited company based in Mumbai, Maharashtra, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 04 May 1995 (31+ years old) and is registered under CIN U67120MH1995PLC088000.
Relic Pharma has 3 current directors:
- Hemant Kantilal Choksey - Director
- Baijoo Madhusudan Raval - Director
- Uday Madhusudan Raval - Director
No. Relic Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Relic Pharma is U67120MH1995PLC088000. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relic Pharma was incorporated on 04 May 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
Hemant Kantilal Choksey ceased to be Additional Director on 30 Sep 2014. Hemant Kantilal Choksey was appointed as Director on 19 Apr 2014. Madhusudan Mohanlal Raval ceased to be Director on 08 Apr 2014. Relic Pharma has 6 board changes on record in total.
The registered office of Relic Pharma is at J – Block Bhangwadi Shopping Centre Kalbadevi Road, Mumbai, Maharashtra, India – 400002.
Relic Pharma has an authorised share capital of ₹3.25 Cr and a paid-up capital of ₹1 Cr.
Relic Pharma operates in the financial services industry, in the brokerage and trading services segment.
No. Relic Pharma is not listed on any stock exchange. It is an unlisted company.